Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E.
Other stock markets
 03:59:57 2024-07-12 pm EDT 		5-day change 1st Jan Change
3.05 CAD +2.35% Intraday chart for NervGen Pharma Corp. -6.44% +12.96%
Jun. 26 Nervgen Pharma Initiated at Market Perform, $3 Price Target at Raymond James MT
Jun. 25 NervGen Pharma to Advance New Drug Candidate into Preclinical Proof-of-Concept Stage MT

Evolution of the average Target Price on NervGen Pharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

b3f1f0655ffb3fb7b03924bba03291.HcIHYa_JxkjuDkv5nSyi00xHay9Hx5oS3Z0ezICFFUs.c5E_CM2ErQGfVzqO92_lvTwkI0Byv9NnsqhSvMfaJgNblWIbn5-KJYxbEg~ddd0573f1e43931bb56533bede22a9bd

Analyst Recommendations on NervGen Pharma Corp.

Nervgen Pharma Initiated at Market Perform, $3 Price Target at Raymond James MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.98 CAD
Average target price
4.5 CAD
Spread / Average Target
+51.01%
High Price Target
5 CAD
Spread / Highest target
+67.79%
Low Price Target
4 CAD
Spread / Lowest Target
+34.23%

Consensus detail

Consensus revision (last 18 months)

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. Consensus NervGen Pharma Corp.